Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Jul 2025, 6:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Clobazam Tablets (V2) (Q2)
Brimonidine Tartrate + Timolol Maleate Drops (V2) (Q2) Bisacodyl Tablets (V2) (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 2 Lakh (s) ( ( 3 3 ))
7938679
GEM/2025/B/6319547
Two Packet Bid
Bisacodyl Tablets (V2)
2 days
Tartrate + Timolol Maleate Drops (V2) ( 594 pieces ) ( 1 2 Minimum 50% and 20% Local Content required for qualifying as Class 1 and Class 2 Local Supplier respectively) Technical Specifications As per GeM Category Specification Specification Specification Name PACKAGING Primary pack size 10 ml 4/20 Consignees/Reporting Officer and Quantity .... S.No. Consignee Reporting/Officer Address Quantity 1 JALANDHAR CITY 594 Bisacodyl Tablets (V2) (129000tablet(s) ) (
Item wise consignee wise evaluation
PRODUCT
7 documents required · 7 mandatory
₹2 L
80%
Exempted
2 Jul 2025
9 Jul 2025
1 Jul 2025
Clobazam Tablets (V2) (Q2)
Brimonidine Tartrate + Timolol Maleate Drops (V2) (Q2) Bisacodyl Tablets (V2) (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 2 Lakh (s) ( ( 3 3 ))
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7938679.pdf
GEM_BID
ATC_e8861a6b-8550-4732-9b8a1750507661562_USINGH1972.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .